SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-005912
Filing Date
2024-04-26
Accepted
2024-04-26 16:15:29
Documents
4
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20240613xdef14a.htm DEF 14A 571531
2 GRAPHIC tmb-20240613xdef14a_a001.jpg GRAPHIC 5269
3 GRAPHIC tmb-20240613xdef14a_bg001.jpg GRAPHIC 111141
4 GRAPHIC tmb-20240613xdef14a_bg002.jpg GRAPHIC 102221
  Complete submission text file 0001558370-24-005912.txt   874217
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40523 | Film No.: 24883963
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)